Top Markets
Coin of the day
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
株式のランク #39234
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
株価
$0.0045
最終同期: 2026-08-13
時価総額
$591.52K
変化(1日)
-10.00%
変化(1年)
-86.76%
US
取引 Burzynski Research Institute, Inc. (BZYR)

カテゴリー

Burzynski Research Institute, Inc.(BZYR)の配当利回りの履歴
Burzynski Research Institute, Inc.(銘柄コード: BZYR)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Burzynski Research Institute, Inc.(BZYR)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)